INTERACTION BETWEEN THE RETINOBLASTOMA PROTEIN AND THE ONCOPROTEIN MDM2

被引:549
|
作者
XIAO, ZX
CHEN, JD
LEVINE, AJ
MODJTAHEDI, N
XING, J
SELLERS, WR
LIVINGSTON, DM
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[2] PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544
关键词
D O I
10.1038/375694a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
INACTIVATION of tumour-suppressor genes leads to deregulated cell proliferation and is a key factor in human tumorigenesis. Both p53 and retinoblastoma genes are frequently mutated in human cancers(1,2), and the simultaneous inactivation of RB and p53 is frequently observed in a variety of naturally occurring human tumours(3). Furthermore, three distinct DNA tumour virus groups papovaviruses, adenoviruses and human papillomaviruses-transform cells by targeting and inactivating certain functions of both the p53 and retinoblastoma proteins(1,2). The cellular oncoprotein, Mdm2, binds to and downmodulates p53 function(4-6); its human homologue, MDM2, is amplified in certain human tumours, including sarcomas(7-9) and gliomas(10). Overproduction of Mdm2 is both tumorigenic(4) and capable of immortalizing primary rat embryo fibroblasts(11). Here we show that MDM2 interacts physically and functionally with pRB and, as with p53, inhibits pRB growth regulatory function. Therefore, both pRB and p53 can be subjected to negative regulation by the product of a single cellular proto-oncogene.
引用
收藏
页码:694 / 698
页数:5
相关论文
共 50 条
  • [41] Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer
    Hori, M
    Yokose, T
    Itabashi, M
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 38A - 38A
  • [42] Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer
    Hori, M
    Yokose, T
    Itabashi, M
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 38A - 38A
  • [43] On the interaction between p53 and MDM2: Transfer NOE study of a p53-derived peptide ligated to MDM2
    Blommers, MJJ
    Fendrich, G
    GarciaEcheverria, C
    Chene, P
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (14) : 3425 - 3426
  • [44] Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein MDM2
    Zou, Xianlin
    Liu, Jingjing
    Gotoh, Tetsuya
    Brown, Anne M.
    Jiang, Liang
    Wisdom, Esther L.
    Kim, Jae Kyoung
    Finkielstein, Carla V.
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [45] Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer
    Hori, M
    Shimazaki, J
    Inagawa, S
    Itabashi, M
    Hori, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 71 (01) : 77 - 83
  • [46] Overexpression of SKI Oncoprotein Leads to p53 Degradation through Regulation of MDM2 Protein Sumoylation
    Ding, Boxiao
    Sun, Yin
    Huang, Jiaoti
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (18) : 14621 - 14630
  • [47] Impact of Ser17 Phosphorylation on the Conformational Dynamics of the Oncoprotein MDM2
    Bueren-Calabuig, Juan A.
    Michel, Julien
    [J]. BIOCHEMISTRY, 2016, 55 (17) : 2500 - 2509
  • [48] Does the acidic domain of the MDM2 oncoprotein have a transcriptional control function?
    Bladen, C
    Lunec, J
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 60 - 60
  • [49] Characterizing the protein–protein interaction between MDM2 and 14-3-3σ; proof of concept for small molecule stabilization
    Ward J.A.
    Romartinez-Alonso B.
    Kay D.F.
    Bellamy-Carter J.
    Thurairajah B.
    Basran J.
    Kwon H.
    Leney A.C.
    Macip S.
    Roversi P.
    Muskett F.W.
    Doveston R.G.
    [J]. Journal of Biological Chemistry, 2024, 300 (02)
  • [50] The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma
    Waters, Alicia M.
    Beierle, Elizabeth A.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (01) : 46 - 51